Global Human Fibrinogen Supply, Demand and Key Producers, 2026-2032

The global Human Fibrinogen market size is expected to reach $ 2846 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).

Human Fibrinogen is a high-purity plasma protein preparation derived from human plasma or produced through recombinant technology, with fibrinogen as its main component. It plays a crucial role in blood clotting, as fibrinogen is converted into fibrin by thrombin to form a blood clot and stop bleeding. Fibrinogen concentrate is primarily used to treat congenital or acquired fibrinogen deficiencies, manage bleeding during surgery or trauma, and address other conditions requiring rapid fibrinogen supplementation.

The market for fibrinogen concentrate is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

This report studies the global Human Fibrinogen production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Fibrinogen and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Fibrinogen that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Human Fibrinogen total production and demand, 2021-2032, (Kg)

Global Human Fibrinogen total production value, 2021-2032, (USD Million)

Global Human Fibrinogen production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Kg), (based on production site)

Global Human Fibrinogen consumption by region & country, CAGR, 2021-2032 & (Kg)

U.S. VS China: Human Fibrinogen domestic production, consumption, key domestic manufacturers and share

Global Human Fibrinogen production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Kg)

Global Human Fibrinogen production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Kg)

Global Human Fibrinogen production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Kg)

This report profiles key players in the global Human Fibrinogen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, LFB Group, Shanghai RAAS Blood Products, China Resources Boya Bio-pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, China Meheco Group, Octapharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Fibrinogen market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kg) and average price (USD/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Human Fibrinogen Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Human Fibrinogen Market, Segmentation by Type:
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate

Global Human Fibrinogen Market, Segmentation by Application:
Congenital Fibrinogen Deficiency
Surgical Procedures
Others

Companies Profiled:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
China Resources Boya Bio-pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
China Meheco Group
Octapharma

Key Questions Answered:

1. How big is the global Human Fibrinogen market?

2. What is the demand of the global Human Fibrinogen market?

3. What is the year over year growth of the global Human Fibrinogen market?

4. What is the production and production value of the global Human Fibrinogen market?

5. Who are the key producers in the global Human Fibrinogen market?

6. What are the growth factors driving the market demand? Show more